Biotech Specialty Pharma

Celldex Therapeutics

119 Fourth Avenue
Needham, MA 02494 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Pre-clinical and clinical development programs

Management Anthony S. Marucci, Founder, President and Chief Executive Officer; Avery W. ("Chip") Catlin, Senior Vice President and Chief Financial Officer; Tibor Keler, Ph.D., Founder, Senior Vice President and Chief Scientific Officer; Thomas Davis, M.D., Senior Vice President and Chief Medical Officer

Click here for Financial Data
Keywords: biotechnology, antigen presenting cell targeting technology, monoclonal antibodies, dendritic cells, synergistic


Updated: Nov. 21, 2014


Celldex is an innovative biotechnology company focused on the discovery, development and commercialization of targeted immunotherapies. Their core focus includes the use of tumor-specific targets and ......view more

Technology / Differentiation

Celldex's proprietary technology platform uses fully human monoclonal antibodies administered directly to patients to target dendritic cells and macrophages key cells within the immune system. To gen...view more

Competitors / Substitutes / Alternatives

CancerVax Corporation (CNVX), Corixa Corporation (CRXA), Dendreon Corporation (DNDN)...view more